05.12.20 -- Oligonucleotide Therapeutics: New Drugs That Could Stop COVID-19

Pediatric drug development requires a formulation designed to fit the specific needs of that patient population. Not considering these requirements early enough could add significant delays.

There is a continued demand for novel, fit-for-purpose immunoassays. Despite the challenges, it’s important for assay developers to streamline the selection and potential modification of critical reagents to get their tests to market quicker.

A client exploring the re-purposing of antifungal CYP51A1 inhibitors for targeting cancers found a screening assay and screening of client compounds moved the project forward in a cost-effective manner. 

Protein thermal shift assays enable quick and easy buffer optimization for increased protein stability. Learn more about the CFX Real-Time PCR Detection Systems which uses a simple protocol to measure protein thermal stability using SYPRO Orange Fluorescent Dye.